- Home
- LSTA vs GROW Comparison
LSTA vs GROW Comparison
Compare LSTA & GROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSTA
- GROW
- Stock Information
- Founded
- LSTA 1980
- GROW 1968
- Country
- LSTA United States
- GROW United States
- Employees
- LSTA N/A
- GROW N/A
- Industry
- LSTA Misc Health and Biotechnology Services
- GROW Investment Managers
- Sector
- LSTA Health Care
- GROW Finance
- Exchange
- LSTA Nasdaq
- GROW Nasdaq
- Market Cap
- LSTA 22.3M
- GROW 32.2M
- IPO Year
- LSTA N/A
- GROW N/A
- Fundamental
- Price
- LSTA $2.28
- GROW $2.51
- Analyst Decision
- LSTA Strong Buy
- GROW
- Analyst Count
- LSTA 2
- GROW 0
- Target Price
- LSTA $23.50
- GROW N/A
- AVG Volume (30 Days)
- LSTA 21.5K
- GROW 23.0K
- Earning Date
- LSTA 11-11-2025
- GROW 09-08-2025
- Dividend Yield
- LSTA N/A
- GROW 3.56%
- EPS Growth
- LSTA N/A
- GROW N/A
- EPS
- LSTA N/A
- GROW N/A
- Revenue
- LSTA $1,070,000.00
- GROW $8,452,000.00
- Revenue This Year
- LSTA N/A
- GROW N/A
- Revenue Next Year
- LSTA N/A
- GROW N/A
- P/E Ratio
- LSTA N/A
- GROW N/A
- Revenue Growth
- LSTA N/A
- GROW N/A
- 52 Week Low
- LSTA $1.87
- GROW $2.02
- 52 Week High
- LSTA $4.20
- GROW $2.68
- Technical
- Relative Strength Index (RSI)
- LSTA 46.32
- GROW 57.55
- Support Level
- LSTA $2.10
- GROW $2.39
- Resistance Level
- LSTA $2.33
- GROW $2.57
- Average True Range (ATR)
- LSTA 0.17
- GROW 0.06
- MACD
- LSTA 0.01
- GROW 0.01
- Stochastic Oscillator
- LSTA 43.75
- GROW 66.67
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.
About GROW U.S. Global Investors Inc.
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.